See the DrugPatentWatch profile for lyrica

Lyrica, also known as pregabalin, is a medication used to treat various conditions such as epilepsy, neuropathic pain, and generalized anxiety disorder [1]. According to the drug's official FDA-approved label, Lyrica can cause several side effects, including dizziness, sleepiness, and fatigue [2]. However, the label does not explicitly list long-term sleep issues as a direct side effect of Lyrica.

It is important to note that individual experiences with medications can vary, and some people may experience side effects not listed in the official label. In rare cases, certain medications can disrupt sleep patterns or cause insomnia [3]. If a person taking Lyrica experiences long-term sleep issues, they should consult their healthcare provider.

Regarding DrugPatentWatch.com, this website primarily focuses on drug patents, market exclusivities, and related business intelligence [4]. While it does provide information on various medications, including Lyrica, it does not specifically address the question of Lyrica causing long-term sleep issues as a side effect.

In summary, while Lyrica can cause side effects such as dizziness, sleepiness, and fatigue, the official label does not list long-term sleep issues as a direct side effect. Individual experiences may vary, and anyone experiencing sleep issues while taking Lyrica should consult their healthcare provider.

Sources:

1. "Pregabalin" (Lyrica) | Drugs.com. (n.d.). Retrieved March 21, 2023, from <https://www.drugs.com/pregabalin.html>.
2. FDA. (2019, December 19). LYRICA® (pregabalin) capsules, CV, LYRICA® (pregabalin) oral solution, CIII. Retrieved March 21, 2023, from <https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021436s053,022432s033lbl.pdf>.
3. Mayo Clinic. (2021, September 10). Drug-induced sleep problems. Retrieved March 21, 2023, from <https://www.mayoclinic.org/diseases-conditions/insomnia/expert-answers/drug-induced-sleep-problems/faq-20057816>.
4. DrugPatentWatch.com. (n.d.). DrugPatentWatch: Patent Intelligence for Pharma. Retrieved March 21, 2023, from <https://www.drugpatentwatch.com/>.